Morning Briefing
Summaries of health policy coverage from major news organizations
Obama Signals Interest In Reducing The Protections For Biologic Drugs
Lobbyists for generic biologic drugmakers are fighting to undercut a provision that would protect brand-name pharmaceutical companies from lower-cost, generic competition over new products for 12 years.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
